Compounds and compositions as protein kinase inhibitors

Details for Australian Patent Application No. 2010286569 (hide)

Owner Novartis AG IRM LLC

Inventors Huang, Shenlin; Jin, Xianming; Liu, Zuosheng; Poon, Daniel; Tellew, John E.; Wan, Yongqin; Wang, Xing; Xie, Yongping

Agent Davies Collison Cave

Pub. Number AU-A-2010286569

PCT Pub. Number WO2011/025927

Priority 61/313,039 11.03.10 US; 61/238,073 28.08.09 US

Filing date 27 August 2010

Wipo publication date 3 March 2011

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

12 April 2012 PCT application entered the National Phase

  PCT publication WO2011/025927 Priority application(s): WO2011/025927

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010286576-Power line communications apparatus

2010286568-Automated systems and methods for making braided barbed sutures